Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Wilson

Showing results (251-260 of 424) with videos related to

Pageof 43
Sort By:
Atherosclerosis|September 15, 2005
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1qJosée Dupuis, Martin G Larson, Ramachandran S Vasan, et al.
Journal of the American College of Cardiology|July 6, 2004
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring StudyJohn F Keaney, Joseph M Massaro, Martin G Larson, et al.
Hypertension (Dallas, Tex. : 1979)|March 10, 2004
Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart StudyRamachandran S Vasan, Jane C Evans, Emelia J Benjamin, et al.
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Writing Group II: risk factorsSidney C Smith, Richard V Milani, Donna K Arnett, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Associations between vitamin K biochemical measures and bone mineral density in men and womenSarah L Booth, Kerry E Broe, James W Peterson, et al.
Journal of the American Heart Association|August 19, 2024
Measuring Frailty Using Self-Report or Automated Tools to Identify Risk of Cardiovascular Events and Mortality: The Million Veteran ProgramSaadia Qazi, Benjamin Seligman, Sarah R Preis, et al.
Heart Asia|June 22, 2016
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registryS Goto, Y Ikeda, J C N Chan, et al.
International Journal of Cardiology|May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortalityRonan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
Archives of Neurology|November 15, 2006
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart StudyErnst J Schaefer, Vanina Bongard, Alexa S Beiser, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2004
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality InitiativeB Kasiske, F G Cosio, J Beto, et al.
Pageof 43

Showing results (251-260 of 424) with videos related to

Sort By:
Pageof 43
Atherosclerosis|September 15, 2005
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1qJosée Dupuis, Martin G Larson, Ramachandran S Vasan, et al.
Journal of the American College of Cardiology|July 6, 2004
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring StudyJohn F Keaney, Joseph M Massaro, Martin G Larson, et al.
Hypertension (Dallas, Tex. : 1979)|March 10, 2004
Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart StudyRamachandran S Vasan, Jane C Evans, Emelia J Benjamin, et al.
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Writing Group II: risk factorsSidney C Smith, Richard V Milani, Donna K Arnett, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Associations between vitamin K biochemical measures and bone mineral density in men and womenSarah L Booth, Kerry E Broe, James W Peterson, et al.
Journal of the American Heart Association|August 19, 2024
Measuring Frailty Using Self-Report or Automated Tools to Identify Risk of Cardiovascular Events and Mortality: The Million Veteran ProgramSaadia Qazi, Benjamin Seligman, Sarah R Preis, et al.
Heart Asia|June 22, 2016
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registryS Goto, Y Ikeda, J C N Chan, et al.
International Journal of Cardiology|May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortalityRonan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
Archives of Neurology|November 15, 2006
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart StudyErnst J Schaefer, Vanina Bongard, Alexa S Beiser, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2004
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality InitiativeB Kasiske, F G Cosio, J Beto, et al.
Pageof 43